Zacks Investment Research
30 Jul 2026, 23:31 UTC · 11w ago
Eastman Chemical (EMN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Impact · against what's priced in
Eastman Chemical (EMN) delivered a strong Q2 beat on both top and bottom lines, with revenue growing 9.9% year-over-year. This operational strength suggests improved demand and profitability beyond consensus expectations.
- EMN+0.40
No priced-in read yet
- In context
The company beat consensus estimates for both EPS ($1.97 vs $1.80) and revenue ($2.51 billion vs $2.37 billion), signaling stronger-than-expected quarterly performance.
Read from the article alone
Top 2 movers · tap to explore
